1 Proportion of subjects deceased ( 3 months) |
2 |
940 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.43 [0.10, 1.95] |
1.1 galantamine (24‐32mg/d bid) vs placebo |
1 |
386 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.09 [0.00, 1.98] |
1.2 galantamine (32mg/d tds) vs placebo |
1 |
554 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.01 [0.14, 7.25] |
2 Proportion of subjects deceased ( 6 months) |
4 |
4286 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.95 [0.50, 1.78] |
2.1 galantamine (16‐24mg/d bid ) vs placebo |
1 |
651 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.99 [0.06, 15.91] |
2.2 galantamine (16‐24mg/d Prolonged Release ) vs placebo |
1 |
644 |
Odds Ratio (M‐H, Fixed, 95% CI) |
3.06 [0.32, 29.54] |
2.3 galantamine (24mg/d bid) vs placebo |
3 |
1576 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.83 [0.35, 1.98] |
2.4 galantamine (32mg/d bid or tds) vs placebo |
1 |
424 |
Odds Ratio (M‐H, Fixed, 95% CI) |
3.04 [0.12, 75.12] |
2.5 galantamine (8mg/d bid) vs placebo |
1 |
426 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.06, 4.58] |
2.6 galantamine (16mg/d bid) vs placebo |
1 |
565 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.77 [0.17, 3.46] |
3 Proportion of subjects deceased ( 24 months in MCI) |
2 |
1903 |
Odds Ratio (M‐H, Fixed, 95% CI) |
9.33 [1.72, 50.54] |
3.1 galantamine (16‐24mg/d bid ) vs. placebo in MCI |
2 |
1903 |
Odds Ratio (M‐H, Fixed, 95% CI) |
9.33 [1.72, 50.54] |